ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Runs Afoul Of FDA In Attempt To Distribute Chapters of Oncology Textbook

June 19, 1992

Physician Indicted for Mail Fraud After allegedly Falsifying Data Of Patients On ECOG, CALGB Trials

March 30, 1984

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013

Tobaccos Council Awards New Grants

April 3, 1981

Obama’s Virtual Colonoscopy Sets Off Real-World Turf War Of Specialty Groups.

March 5, 2010